Details for New Drug Application (NDA): 203911
✉ Email this page to a colleague
The generic ingredient in FLUDEOXYGLUCOSE F18 is fludeoxyglucose f-18. There are eight drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the fludeoxyglucose f-18 profile page.
Summary for 203911
Tradename: | FLUDEOXYGLUCOSE F18 |
Applicant: | Nukemed |
Ingredient: | fludeoxyglucose f-18 |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 4-500mCi/ML | ||||
Approval Date: | Apr 22, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription